Evaluation of G-CSF effects on unresponsive thin endometrium and ART outcome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012272576N4

Enrollment

Registered

2011-07-16

Start date

2011-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thin endometrium in ICSI cycles.

Interventions

Intrauterin infusion of GCS-F (300mcg) two days before oocyte pick up.

Treatment - Drugs

Intrauterin infusion of GCS-F (300mcg) two days before oocyte pick up

Eligibility

Sex/Gender

Female

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients who their previous cycles have been canceled because of thin endometrium in spite of receiving standard treatment Exclusion criteria:patients who have hypersensitivity to GCS-F

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Endometrial thickness in transvaginal sonography. Timepoint: In 6th day of I/O and every2 days till thickness 7 mm. Method of measurement: Triple line endometrium in mm in vaginal sonography.	—

Secondary

Measure	Time frame
Biochemical pregnancy. Timepoint: Biochemical pregnancy 2 weeks after embryo transfer. Method of measurement: Measuerment of B-hCG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fatedavari@yahoo.com; fdavaritanha@sina.tums.ac.ir+98 21 8889 7761

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026